Home > H3D News > News
H3D honours Neville Isdell for his generosity and leadership
Mon, 09 Mar 2020 - 09:45



Recently, H3D hosted a lunch in honour of Mr Neville Isdell to thank him for his generosity and leadership. Mr Isdell donated approximately R18 million towards the establishment of a five-year Neville Isdell Chair in African-centric Drug Discovery and Development at H3D. 


The Time is Now for Antimicrobial Research and Development in Africa
Fri, 06 Dec 2019 - 11:00

Antimicrobial resistance (AMR) has been an ongoing threat to public health in South Africa as well as other countries in Africa. Disturbingly, the burden in the continent from infectious diseases has also been on the rise. Part of the reason is the persistence of infections associated with tropical regions as well as the higher rates of poverty and greater spread of drug resistance. 

Chemical Attraction
Fri, 01 Nov 2019 - 17:00

"Prof Kelly Chibale talks about the bonds he has formed through his illustrious career which began in an impoverished Zambian township."

Prof Chibale was featured in this weeks Noseweek Issue #241, 1st November 2019   By Sue Segar

Read the full story here 

Medicines for Africans by Africans
Fri, 18 Oct 2019 - 14:00

Africa accounts for 15% of the global population and 25% of the global disease burden, yet the discovery and development of medicines that end up in Africa has historically only happened in the global north. It is time for the situation to change, says Professor Kelly Chibale, director and founder of the University of Cape Town’s (UCT) Drug Discovery and Development Centre, H3D.

Unlocking Africa's Health Innovation Potential
Tue, 15 Oct 2019 - 14:00

With African-led innovation in drug discovery lower than other continents, the government has a responsibility to address the barriers that stand in the way of creating an innovation-friendly environment.

UCT Shares Expertise to Boost Search for New Drugs
Fri, 27 Sep 2019 - 14:00

Eight innovators from seven African countries have been announced as the inaugural awardees of the Grand Challenges (GC) Africa drug discovery programme. They will be involved in research that will advance the discovery of new drugs to prevent, treat and cure diseases endemic to Africa.

Financial Times: African Scientists Seek Slice of Global Pharmaceutical Industry
Mon, 23 Sep 2019 - 14:00

A feature on Professor Kelly Chibale and H3D has been published in the  UK-based Financial Times, one of the world's leading news organisations. The article can be found here: https://www.ft.com/content/c3e47c32-c8c2-11e9-af46-b09e8bfe60c0

H3D 2020 Symposium
Fri, 15 Mar 2019 - 14:00
Celebrating a Decade in Infectious Diseases Drug Discovery in Africa



Multimillion rand boost for Africa medicines research
Fri, 15 Mar 2019 - 14:00
University of Cape Town (UCT) alumnus and former chairman and chief executive of Coca-Cola Neville Isdell has donated $1 242 160 (about R18 million) towards research into the discovery of new medicines for infectious diseases at the university’s Drug Discovery and Development Centre (H3D).

The generous donation will be used to establish an initial five-year Neville Isdell Chair in African-centric Drug Discovery and Development at H3D. H3D’s director and founder Professor Kelly Chibale will hold the Chair, which includes the directorship of H3D.


Strengthening Capacity for Drug Discovery Research in Africa
Fri, 15 Mar 2019 - 14:00
Course gives comprehensive overview of the drug discovery process with special focus on international and inter-disciplinary collaboration.

In April 2019 Advanced Courses and Scientific Conferences (ACSC) held a one-week course in South Africa entitled ‘Practical Aspects of Drug Discovery: At the Interface of Biology, Chemistry and Pharmacology’.


Drug Discovery in Africa
Fri, 15 Mar 2019 - 14:00


June 5, 2019



Kelly Chibale in the Financial Times
Fri, 15 Mar 2019 - 14:00

The US Financial Times recently featured Kelly Chibale as an Innovator in Drug Discovery in Africa